3 6 Ke·2026-02-04 11:59Core Viewpoint - Qingdao Guoen Technology Co., Ltd. (referred to as "Guoen Technology") has successfully listed on the Hong Kong Stock Exchange, raising a total of HKD 1.08 billion through the issuance of 30 million shares at an offering price of HKD 36 per share [1][3]. Group 1: Company Overview - Guoen Technology specializes in chemical new materials and upstream and downstream products such as gelatin and collagen, serving the chemical and health industries [4]. - The company has a diverse customer base, including manufacturers in the automotive, new energy, and home appliance sectors, as well as pharmaceutical manufacturers in the health sector [4]. - Guoen Technology has made several strategic acquisitions to enhance its vertical integration and expand its presence in the health industry, including the acquisition of Yiqing Bio and Dongbao Bio [4]. Group 2: Financial Performance - The company's revenue for 2022, 2023, and 2024 is projected to be RMB 134 billion, RMB 174.4 billion, and RMB 191.9 billion, respectively, with net profits of RMB 7.2 billion, RMB 5.4 billion, and RMB 7.2 billion during the same periods [5][6]. - For the first ten months of the 2025 fiscal year, Guoen Technology reported revenue of RMB 174.4 billion and a net profit of RMB 7.21 billion [7]. Group 3: Shareholder Structure - The controlling shareholders of Guoen Technology are Wang Aiguo and his wife, holding 56.6% of the shares [8]. - Wang Aiguo, the founder and chairman, holds 46.45% of the shares, while other significant shareholders include Qingdao Century Star Hao Investment Co., Ltd. and Xu Bo [15][16].